Recovery of ocular events with longer-term follow-up in the DREAMM-2 study of single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma

被引：0

作者：

Lonial, Sagar ^{[1
]}

Nooka, Ajay K. ^{[1
]}

Thulasi, Praneetha ^{[2
]}

Badros, Ashraf Z. ^{[3
]}

Jeng, Bennie H. ^{[4
]}

Callander, Natalie S. ^{[5
]}

Sborov, Douglas ^{[6
]}

Zaugg, Brian E. ^{[7
]}

Popat, Rakesh ^{[8
]}

Degli Esposti, Simona ^{[9
,10
]}

Byrne, Julie ^{[11
]}

Opalinska, Joanna ^{[11
]}

Baron, January ^{[11
]}

Piontek, Trisha ^{[11
]}

Gupta, Ira ^{[11
]}

Dana, Reza ^{[12
]}

Farooq, Asim V. ^{[13
]}

Jakubowiak, Andrzej ^{[13
]}

机构：

[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[2] Emory Univ, Emory Eye Ctr, Atlanta, GA 30322 USA

[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA

[4] Univ Maryland, Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA

[5] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[6] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[7] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA

[8] NHS Fdn Trust, Univ Coll London Hosp, London, England

[9] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England

[10] UCL Inst Ophthalmol, London, England

[11] GlaxoSmithKline, Upper Providence, PA USA

[12] Harvard Med Sch, Massachusetts Eye & Ear, Boston, MA 02115 USA

[13] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BSH2021-PO

引用

页码：53 / 54

页数：2